1. Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
2. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA;
3. Hofstra Northwell School of Medicine, Hempstead, NY;
4. Cancer Care Manitoba, Winnipeg, MB, Canada;
5. Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH;
6. Department of Pathology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
7. Centre for Lymphoid Cancer and Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada;
8. Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA; and
9. Cardio-Oncology Program, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN